How
SAFEPATH Works

SAFEPATH integrates cheminformatics and bioinformatics to understand the mechanisms behind drug toxicity. In preclinical and clinical studies, safety assessments typically reveal what went wrong—such as liver failure or cardiac arrest—but fail to explain why these issues occurred or how they might be mitigated.

SAFEPATH combines advanced machine learning models with a multimodal data approach to enable a deep understanding of toxicity mechanisms, offering actionable insights to facilitate drug turnaround.

In this white paper, our Cofounder and Chief Data Science Officer Dr. Layla Hosseini-Gerami explains how our innovative platform works.

Submit
icon
Thank you!
Download
icon
Oops! Something went wrong while submitting the form.

Our Partners

Our Investors

Latest News

All
Blog
13.10.2025
The right drug, wrong patients
All
Event
Media
08.10.2025
The Bucks Herald
Aylesbury High School honours former pupil Dr Layla Hosseini-Gerami.
All
Press release
06.10.2025
Ignota Labs Acquires Kronos’s Clinical Pipeline
All
Blog
13.10.2025
The right drug, wrong patients
All
Event
Media
08.10.2025
The Bucks Herald
Aylesbury High School honours former pupil Dr Layla Hosseini-Gerami.
All
Press release
06.10.2025
Ignota Labs Acquires Kronos’s Clinical Pipeline